[PHARMA] QoQ TTM Result on 30-Jun-2009 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
21-Aug-2009
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2009
Quarter
30-Jun-2009 [#2]
Profit Trend
QoQ- 8.2%
YoY- -12.21%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 30/09/08 CAGR
Revenue 1,304,640 1,300,796 1,305,133 1,289,459 1,309,712 1,305,646 1,270,220 1.80%
PBT 73,685 81,438 78,444 86,658 83,409 90,599 89,675 -12.28%
Tax -17,340 -19,709 -20,911 -24,472 -26,289 -29,190 -29,741 -30.23%
NP 56,345 61,729 57,533 62,186 57,120 61,409 59,934 -4.03%
-
NP to SH 54,977 60,192 56,067 60,598 56,008 60,031 58,311 -3.85%
-
Tax Rate 23.53% 24.20% 26.66% 28.24% 31.52% 32.22% 33.17% -
Total Cost 1,248,295 1,239,067 1,247,600 1,227,273 1,252,592 1,244,237 1,210,286 2.08%
-
Net Worth 439,675 431,217 407,858 400,161 402,378 388,298 374,393 11.32%
Dividend
31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 30/09/08 CAGR
Div 97,382 97,382 86,673 57,770 48,140 48,140 38,516 85.69%
Div Payout % 177.13% 161.79% 154.59% 95.33% 85.95% 80.19% 66.05% -
Equity
31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 30/09/08 CAGR
Net Worth 439,675 431,217 407,858 400,161 402,378 388,298 374,393 11.32%
NOSH 106,977 107,001 107,049 106,995 107,015 106,969 106,969 0.00%
Ratio Analysis
31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 30/09/08 CAGR
NP Margin 4.32% 4.75% 4.41% 4.82% 4.36% 4.70% 4.72% -
ROE 12.50% 13.96% 13.75% 15.14% 13.92% 15.46% 15.57% -
Per Share
31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 30/09/08 CAGR
RPS 1,219.55 1,215.67 1,219.19 1,205.16 1,223.85 1,220.58 1,187.46 1.79%
EPS 51.39 56.25 52.37 56.64 52.34 56.12 54.51 -3.85%
DPS 91.00 91.00 81.00 54.00 45.00 45.00 36.00 85.66%
NAPS 4.11 4.03 3.81 3.74 3.76 3.63 3.50 11.31%
Adjusted Per Share Value based on latest NOSH - 106,995
31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 30/09/08 CAGR
RPS 90.52 90.26 90.56 89.47 90.87 90.59 88.13 1.80%
EPS 3.81 4.18 3.89 4.20 3.89 4.17 4.05 -3.99%
DPS 6.76 6.76 6.01 4.01 3.34 3.34 2.67 85.86%
NAPS 0.3051 0.2992 0.283 0.2777 0.2792 0.2694 0.2598 11.32%
Price Multiplier on Financial Quarter End Date
31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 30/09/08 CAGR
Date 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 30/09/08 -
Price 4.27 4.00 4.09 3.80 3.45 3.36 3.24 -
P/RPS 0.35 0.33 0.34 0.32 0.28 0.28 0.27 18.90%
P/EPS 8.31 7.11 7.81 6.71 6.59 5.99 5.94 25.11%
EY 12.04 14.06 12.81 14.90 15.17 16.70 16.82 -19.99%
DY 21.31 22.75 19.80 14.21 13.04 13.39 11.11 54.43%
P/NAPS 1.04 0.99 1.07 1.02 0.92 0.93 0.93 7.74%
Price Multiplier on Announcement Date
31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 30/09/08 CAGR
Date 26/05/10 19/02/10 13/11/09 21/08/09 08/05/09 27/02/09 24/11/08 -
Price 4.71 4.05 3.93 4.00 3.82 2.73 3.35 -
P/RPS 0.39 0.33 0.32 0.33 0.31 0.22 0.28 24.74%
P/EPS 9.16 7.20 7.50 7.06 7.30 4.86 6.15 30.45%
EY 10.91 13.89 13.33 14.16 13.70 20.56 16.27 -23.40%
DY 19.32 22.47 20.61 13.50 11.78 16.48 10.75 47.87%
P/NAPS 1.15 1.00 1.03 1.07 1.02 0.75 0.96 12.80%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment